RAPID THERAPEUTIC SCIENCE LABORATORIES, INC.

Rapid Therapeutic Science Laboratories, Inc.

RTSL

US7534312043

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 07:02:12 01/07/2024 pm IST			5-day change	1st Jan Change
0.0012 ^USD	0.00%		0.00%	-70.73%

2023	Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
2023	Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

Rapid Therapeutic Science Laboratories, Inc. Announces Completion of New ISO 13485 Laboratory

August 18, 2020 at 04:30 pm IST

Rapid Therapeutic Science Laboratories, Inc. announced its new ISO 13485 laboratory is ready to begin manufacturing the Company’s new consumer-focused, nhaler brand.

Latest news about Rapid Therapeutic Science Laboratories, Inc.

Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31	CI
Rapid Therapeutic Science Laboratories, Inc. Auditor Raises 'Going Concern' Doubt	30/23/30	CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11	CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	13/22/13	CI
Rapid Therapeutic Science Laboratories, Inc. announced that it has received $0.35 million in funding	31/22/31	CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	12/22/12	CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	17/22/17	CI
Rapid Therapeutic Science Laboratories, Inc. Auditor Raises 'Going Concern' Doubt	16/22/16	CI
Rapid Therapeutic Science Laboratories, Inc. announced that it has received $0.4 million in funding	28/22/28	CI
Rapid Therapeutic Science Laboratories, Inc. announced that it has received $0.15375 million in funding from Sixth Street Lending, LLC	18/22/18	CI
Rapid Therapeutics Science Laboratories Announces Launch of its New Facility Located in Addison, Tex	11/21/11	CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	10/21/10	CI
Rapid Therapeutic Science Laboratories Appoints Justin Suggs to Its Board of Directors	02/21/02	CI
Rapid Therapeutic Science Laboratories, Inc. Appoints Henry A. Punzi, as A Member of the Board of Directors	26/21/26	CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	12/21/12	CI
Rapid Therapeutic Science Laboratories, Inc. Appoints J. Scott Suggs as Member of the Board of Directors and as Chairperson (And Sole Member) of the Company's Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee	06/21/06	CI
Rapid Therapeutic Science Laboratories, Inc. announced that it has received $1.65 million in funding from Armistice Capital LLC	04/21/04	CI
Rapid Therapeutic Science Laboratories, Inc. announced that it expects to receive $1.65 million in funding from Armistice Capital LLC	01/21/01	CI
Rapid Therapeutic Finalizes Lab Work on Pharmaceutical Formulas	10/21/10	CI
Rapid Therapeutic Prepares to File Investigational New Drug Application for its CBD Metered Dose Inhaler with FDA	02/21/02	CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	14/21/14	CI
Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Nine Months Ended December 31, 2020	17/21/17	CI
Empower : Holley to Go Public in Merger With Bank-Check Company Empower	12/21/12	MT

Chart Rapid Therapeutic Science Laboratories, Inc.

Duration

Period

Chart Rapid Therapeutic Science Laboratories, Inc.

More charts

Rapid Therapeutic Science Laboratories, Inc. is a biopharmaceutical company. The Company is focused on developing potential commercial opportunities which involve the rapid application of therapeutics using inhaler technology. The Company has developed a method of formulating and manufacturing pressurized metered dose inhalers (pMDI) that contain and properly aerosolize proprietary formula of one or more patent pending pharmaceutical-grade cannabinoid compounds. It has developed and is continuing to develop a series of complementary products in addition to its inhaler. It is also focusing on manufacturing its own branded MDI under the nhaler brand name.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
RAPID THERAPEUTIC SCIENCE LABORATORIES, INC.	-70.73%	22.78K
DONG-E-E-JIAO CO.,LTD.	+22.67%	5.41B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-35.93%	3.52B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-6.69%	2.96B
TASLY PHARMACEUTICAL GROUP CO., LTD	-27.73%	2.6B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-11.46%	2.29B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+38.57%	1.89B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+38.46%	1.47B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-16.41%	1.43B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+42.86%	1.36B